Bayer’s stock is jumping on secondary stroke drug’s trial success

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Previous Article

FAA Prepared For Busiest Thanksgiving Travel In 15 Years

Next Article

Luxembourgers Are The World's Biggest Coffee Drinkers

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

+ 14 = 18
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨